Company Team Search Site Map Careers Privacy Statement
:: Home
:: About Us
:: Research
:: Products
:: Services
:: Facilities
:: Contact us
Virchow Products
Biotech R&D

Our dedicated research facility is recognized by Government of India.

Our R&D center has a Doctoral Program (Ph.D) that is registered with Jawarlal Nehru Techonlogoical University, Osmania University, Nagarjuna University and Andhra University.

VBPL also has ongoing collaborative research projects with internationally reputable CSIR labs like Center for Cellular and Molecular Biology, Indian Institute of Chemical Technology, National Institutes of Nutrition and University of Michigan, USA.

Clinical Trials

Virchow's full fledged clinical team is equipped with state of the art tools to conduct pre-clinical and clinical trials. Since its inception we have conducted more than 15 pre-clinical and Clinical studies. Our clinical trials are crucial to the exploration of new therapies that might address unmet medical needs. Virchow places high priority on communicating information about clinical trials. We share all our information with the Physicians and routinely publish our clinical trial results in peer reviewed journals.

News & Events

Virchow Biotech is filing for U.S.Food and Drug administration’s (FDA) approval for its in house developed advanced wound care products.

Virchow Biotech received Drug control’s (DCGI) approval for conducting clinical trials on periogen, an indigenously developed recombinant therapeutic product for periodontal diseases

Virchow Biotech and Ranbaxy signed an MOU to market Virchow’s indigenously developed recombinant therapeutic protein for osteoporosis treatment. We are the first in the world to launch this biogeneric product